These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28851537)

  • 1. Use of a collaborative tool to simplify the outsourcing of preclinical safety studies: an insight into the AstraZeneca-Charles River Laboratories strategic relationship.
    Martin FDC; Benjamin A; MacLean R; Hollinshead DM; Landqvist C
    Drug Discov Today; 2017 Dec; 22(12):1754-1759. PubMed ID: 28851537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taking the pulse of strategic outsourcing relationships.
    Getz KA; Lamberti MJ; Kaitin KI
    Clin Ther; 2014 Oct; 36(10):1349-55. PubMed ID: 25444564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future trends in outsourcing: a summary of the Bioanalysis Zone Survey.
    Craddock A; Nadarajah S
    Bioanalysis; 2017 Aug; 9(15):1127-1129. PubMed ID: 28766363
    [No Abstract]   [Full Text] [Related]  

  • 4. AstraZeneca and Covance Laboratories Clinical Bioanalysis Alliance: an evolutionary outsourcing model.
    Arfvidsson C; Severin P; Holmes V; Mitchell R; Bailey C; Cape S; Li Y; Harter T
    Bioanalysis; 2017 Aug; 9(15):1181-1194. PubMed ID: 28762755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outsourcing chemical synthesis in the drug discovery process.
    Festel G
    Drug Discov Today; 2011 Mar; 16(5-6):237-43. PubMed ID: 21262378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nature of outsourced preclinical research--the example of chemical synthesis.
    Festel GW
    Expert Opin Drug Discov; 2013 Sep; 8(9):1049-55. PubMed ID: 23725522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do the top 12 pharmaceutical companies operate safety pharmacology?
    Ewart L; Gallacher DJ; Gintant G; Guillon JM; Leishman D; Levesque P; McMahon N; Mylecraine L; Sanders M; Suter W; Wallis R; Valentin JP
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):66-70. PubMed ID: 22510338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of the Pharma-CRO working relationship: AstraZeneca and Covance.
    Bioanalysis; 2017 Aug; 9(15):1171-1174. PubMed ID: 28795581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A community of practice approach to bioanalysis delivery: the role of the Preclinical Bioanalysis and Toxicokinetics department at AstraZeneca.
    Wilson A; Silvester S; Woods K
    Bioanalysis; 2014 May; 6(10):1329-37. PubMed ID: 24958117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions.
    Ewart L; Milne A; Adkins D; Benjamin A; Bialecki R; Chen Y; Ericsson AC; Gardner S; Grant C; Lengel D; Lindgren S; Lowing S; Marks L; Moors J; Oldman K; Pietras M; Prior H; Punton J; Redfern WS; Salmond R; Skinner M; Some M; Stanton A; Swedberg M; Finch J; Valentin JP
    J Pharmacol Toxicol Methods; 2013; 68(1):30-43. PubMed ID: 23665080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrity and efficiency: AbbVie's journey of building an integrated nonregulated bioanalytical laboratory.
    Wang YT; Maes EM; Heinle L; Ruterbories K; Doktor S; Larsen M; Olson A; Lee A; Van Handel C; Ji QC; Desino K; Jenkins GJ
    Bioanalysis; 2023 Feb; 15(3):161-176. PubMed ID: 36961367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outsourcing of bioanalysis at GSK: a hybrid approach with a robust support model.
    Abberley L
    Bioanalysis; 2017 Aug; 9(15):1139-1144. PubMed ID: 28762760
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioanalytical outsourcing strategy at Janssen Research and Development.
    Verhaeghe T
    Bioanalysis; 2014 May; 6(10):1321-7. PubMed ID: 24958116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful outsourcing: improving quality of life through integrated support services.
    Bates J; Sharratt M; King J
    Healthc Manage Forum; 2014; 27(1 Suppl):S58-78. PubMed ID: 25046971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioanalytical outsourcing: the two sides of the medal.
    Zimmer D
    Bioanalysis; 2013 Sep; 5(17):2095-9. PubMed ID: 23962249
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioanalytical outsourcing models in pharmaceutical companies.
    Zimmer D
    Bioanalysis; 2017 Aug; 9(15):1145-1148. PubMed ID: 28763250
    [No Abstract]   [Full Text] [Related]  

  • 18. Outsourcing lead optimisation--the quiet revolution.
    Clark DE; Newton CG
    Drug Discov Today; 2004 Jun; 9(11):492-500. PubMed ID: 15149625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving Outsourcing Landscape in Pharma R&D: Different Collaborative Models and Factors To Consider When Choosing a Contract Research Organization.
    DeCorte BL
    J Med Chem; 2020 Oct; 63(20):11362-11367. PubMed ID: 32479727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing strategic outsourcing in the healthcare industry.
    Roberts V
    J Healthc Manag; 2001; 46(4):239-49. PubMed ID: 11482242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.